LBA98 Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial
- Resource Type
- Abstract
- Authors
- Proto, C.; Manglaviti, S.; Galli, G.; Imbimbo, M.; Alvisi, M.F.; Zollo, F.; Perrino, M.R.A.; Giuliano, M.; Pietroluongo, E.; Ballatore, Z.; Chella, A.; Fabbri, A.; Vigorito, R.; De Braud, F.G.M.; Pasello, G.; Petrini, I.; Berardi, R.; Zucali, P.A.; Ganzinelli, M.; Garassino, M.C.; Lo Russo, G.
- Source
- In Annals of Oncology October 2023 34 Supplement 2:S1337-S1337
- Subject
- Language
- ISSN
- 0923-7534